IL-8 is highly secreted by tumor-associated macrophages and through a complex cytokine network can differentiate macrophages into immune-suppressing M2-like phenotype, which aggravate inflammatory breast cancer (IBC) progression. This evidence concerns the gene CXCL8 and inflammatory breast carcinoma.